MYELOMA

This study tested whether taking lenalidomide (Revlimid) after a stem cell transplant helps keep multiple myeloma from coming back longer. Over 600 patients under age 65 who had no signs of progression after transplant took either lenalidomide or a placebo. The goal was to see if…

This study looked at whether a stem cell transplant from a matched donor could help younger myeloma patients (under 65) who had already responded well to their first transplant. The goal was to improve how long patients lived without the disease getting worse. Patients received a…

This study tested a new medicine, elranatamab, in 39 Chinese adults with multiple myeloma that stopped responding to several standard treatments. The drug works by helping the body's immune system attack the cancer cells. The goal was to see if the drug is safe and can shrink or …

This early-stage trial tested a new cell therapy called FT576, given alone or with another drug (daratumumab), in 31 people with multiple myeloma that had returned or stopped responding to prior treatments. The main goals were to find safe doses and check for side effects. The st…

This study looked at a combination of three drugs (bortezomib, lenalidomide, and dexamethasone, or VRD) for people newly diagnosed with multiple myeloma, a type of blood cancer. Over 400 patients received VRD therapy, and some also had a stem cell transplant. The goal was to cont…

This early-phase study tested a new drug combination (duvelisib plus BMS-986345) in 14 people with blood cancers like lymphoma, myeloma, or leukemia. The main goal was to find a safe dose and check for side effects. Researchers also looked at how well the cancer responded after 3…

This study looked at 700 adults up to age 65 with multiple myeloma to see if high-dose therapy with a stem cell transplant works better than standard drug treatment. The goal was to find out which approach keeps the cancer from growing longer. Results help doctors decide the best…

This study looked at whether covering the cost of blood transfusions would encourage people with blood cancers to enroll in hospice earlier. Many patients delay hospice because they need regular transfusions for symptom relief, which hospices often can't afford. The study offered…

This early study looked at whether repeated hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) is safe for people with multiple myeloma who are about to receive high-dose chemotherapy and a stem cell transplant. 29 adults with myeloma took part. The main g…

This study looked at whether a home-based exercise program is practical for people aged 65 and older with lymphoma, leukemia, or myeloma who are about to receive CAR-T cell therapy. Twenty participants were asked to do supervised resistance training and moderate aerobic exercise.…

This early-phase study looked at whether it is safe and possible to remove a specific type of immune cell (regulatory T cells) in 30 people with multiple myeloma who were getting a stem cell transplant using their own cells. The goal was to see if this removal could be done effec…

This study looked at whether non-invasive methods like a blood test (liquid biopsy) and whole-body MRI can accurately detect leftover cancer cells (minimal residual disease) in people with multiple myeloma. Researchers enrolled 36 newly diagnosed or previously treated patients. T…

This study looked at how well the Pfizer COVID-19 vaccine works in adults with weakened immune systems (like kidney transplant patients, people with cancer, or those on dialysis) compared to healthy adults. Researchers measured antibody levels and their ability to neutralize the …